Search Results - "Torres-Roca, J.F."

Response to Mistry: Radiosensitivity index is not fit to be used for dose adjustments: A pan-cancer analysis.

Authors: Torres-Roca, J.F. Eschrich, S.A. Kattan, M.W. et al.

Source: Clinical Oncology. Sep2023, Vol. 35 Issue 9, p621-623. 3p.

Classification of Radiosensitivity Index by Gaussian Mixture Modelling to Inform Radiotherapy Dose and Discover Disease Subclassifications.

Authors: Sedor, G. Torres-Roca, J.F. Abazeed, M. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2019 Supplement, Vol. 105, pE797-E798. 2p.

Subjects: Gaussian mixture models, Cumulative distribution function, Classification, Radiotherapy, Diseases

A Generalizable Competing Hazards Model of Radiation Associated Outcome Assuming Biological Heterogeneity.

Authors: Sedor, G. Torres-Roca, J.F. Kattan, M.W. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2019 Supplement, Vol. 105, pE798-E798. 1p.

Subjects: Proportional hazards models, Radiation, Heterogeneity

Personalizing Prescription of Radiation Therapy Utilizing Genomic Markers of Radiosensitivity.

Authors: Torres-Roca, J.F. Waller, A.F. Grass, G.D. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2018 Supplement, Vol. 102, pS4-S4. 1p.

A Genomic Framework for Precision Radiation Therapy.

Authors: Scott, J.G. Torres-Roca, J.F. Harrison, L.B. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2016 Supplement, Vol. 96, pS215-S216. 1p.

Subjects: Cancer radiotherapy, Radiation doses, Dose fractionation, Oncology research, Proportional hazards models

Genetic Characterization of Radioresistance in Colorectal Cancer.

Authors: Torres-Roca, J.F. Teer, J. Jin, W. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2015 Supplement, Vol. 93 Issue 3, pS124-S124. 1p.

Subjects: Colon cancer treatment, Drug resistance, Cancer radiotherapy, Genetics of colon cancer, Oncology

Integrating a Molecular Signature of Intrinsic Radiosensitivity Into the Classification of Breast Cancer.

Authors: Torres-Roca, J.F. Fulp, W.J. Naghavi, A.O. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2014 Supplement, Vol. 90 Issue 1, pS170-S170. 1p.

Subjects: Cancer radiotherapy, Tumor classification, Breast cancer treatment, Breast cancer diagnosis, Breast cancer patients, Radiation-sensitizing agents, Therapeutics

A Molecular Signature of Radiosensitivity (RSI) is an RT-specific Biomarker in Prostate Cancer.

Authors: Torres-Roca, J.F. Erho, N. Vergara, I. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2014 Supplement, Vol. 90 Issue 1, pS157-S157. 1p.

Subjects: Prostate cancer treatment, Tumor markers, Radiation-sensitizing agents, Cancer radiotherapy, Molecular biology, Prostate cancer patients

Correlation Between Tumor Intrinsic Radiosensitivity and Immune Activation in Solid Tumors.

Authors: Torres-Roca, J.F. Berglund, A. Welsh, E. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2014 Supplement, Vol. 90 Issue 1, pS822-S823. 1p.

Subjects: Cancer immunology, Antineoplastic agents, Radiation-sensitizing agents, Chemokines, Medical databases, Medical protocols

Large-Scale Evaluation of a Molecular Signature of Tumor Intrinsic Radiosensitivity in Solid Tumors.

Authors: Torres-Roca, J.F. Caudell, J.J. Welsh, E. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2014 Supplement, Vol. 90 Issue 1, pS821-S822. 1p.

Subjects: Cancer radiotherapy, Molecular biology, Publishing, Periodical articles, Oncology periodicals

RSI: A Novel Biomarker Predicts RT Therapeutic Benefit in Breast Cancer

Authors: Torres-Roca, J.F. Fulp, W.J. Pawitan, Y. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2011 Supplement, Vol. 81 Issue 2, pS62-S62. 1p.

CPA7, a Novel Stat3 Inhibitor Radiosensitizes Prostate Cancer Cells

Authors: Sekharam, M. Torres-Roca, J.F. Turkson, J. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2005 Supplement 1, Vol. 63, pS483-S483. 1p.

Gene Selection by a Genomic Radiation Sensitivity Classifier is Influenced by the Presence of a Mutated ras Gene

Authors: Torres-Roca, J.F. Eschrich, S. Yeatman, T.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2005 Supplement 1, Vol. 63, pS473-S473. 1p.

A Modern Day Evaluation of Organ Preservation for Muscle Invasive Bladder Cancer at a High-Volume Cancer Center.

Authors: Linkowski, L.C. Sim, A.J. Torres-Roca, J.F. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pe906-e907. 2p.

Subjects: Muscles, Chi-squared test

Adaptive Radiation Fractionation in Head and Neck Cancer through Modeling Tumor Volume Dynamics.

Authors: Scott, E. Zahid, M.U. Caudell, J.J. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2024 Supplement, Vol. 120 Issue 2, pe655-e656. 2p.

A Validation Study on the Impact of Decipher® Testing on Treatment Recommendations in African American and Non-African American Men with Prostate Cancer (VANDAAM STUDY).

Authors: Yamoah, K. Trivedi, P. Awasthi, S. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2024 Supplement, Vol. 120 Issue 2, pS133-S134. 2p.

Habitat Escalated Adaptive Therapy (HEAT): A Phase 2 Trial Utilizing Radiomic Habitat-Directed and Genomic-Adjusted Radiation Dose (GARD) Optimization for High-Grade Soft Tissue Sarcoma.

Authors: Naghavi, A.O. Costello, J. Kim, Y. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2024 Supplement, Vol. 120 Issue 2, pS88-S89. 2p.

Combination of Nivolumab Immunotherapy with Radiation Therapy and Androgen Deprivation Therapy in the Management of Gleason Group 5 Prostate Cancer: Final Analysis of a Phase 2 Trial.

Authors: Bryant, J.M. Sandoval, M.L. Putney, R. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2024 Supplement, Vol. 120 Issue 2, pS57-S57. 1p.

An Analysis of Patients Treated with Stereotactic Body Radiotherapy for Metastatic Urinary Tract Tumors to Identify Predictors of Response.

Authors: Oh, N. Nakashima, J. Chadha, J.S. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2023 Supplement, Vol. 117 Issue 2, pe424-e425. 2p.

Radiosensitivity Molecular Signature Is Predictive of Overall Survival in Glioblastoma.

Authors: Caudell, J.J. Eschrich, S. Torres-Roca, J.F.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2014 Supplement, Vol. 90 Issue 1, pS281-S281. 1p.

Subjects: Glioblastoma multiforme, Radiation-sensitizing agents, Molecular oncology, Temozolomide, Cancer radiotherapy, Gene expression, Patients